Newsletter

BioMedReports Immunomedics Provides Update On Phase 2 Study Of Isactuzumab Govitecan; Hemispherx Reports New Evidence of Amp... http://t.co/z7wEE2pkui
17hreplyretweetfavorite
BioMedReports Movers: Johnson & Johnson, Perrigo Company, AstraZeneca, Acadia Healthcare Company, Charles River Laboratories... http://t.co/sF6jvpM24E
20hreplyretweetfavorite
BioMedReports Cara Therapeutics Announces Positive Results Of Peripheral Opioid; POZEN Appoints Senior VP and Chief Business... http://t.co/yoqxKE9IsH
Benzinga.com supporter Seeking Alpha Certified